Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “ALA Dehydratase Deficient Porphyria (ADP)”

3 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 3 of 3 results

Not applicableApproved For MarketingNCT04056481
What this trial is testing

Expanded Access Protocol of Givosiran for Patients With Acute Hepatic Porphyria

Who this might be right for
Acute Hepatic Porphyria
Alnylam Pharmaceuticals
Large-scale testing (Phase 3)Study completedNCT03338816
What this trial is testing

ENVISION: A Study to Evaluate the Efficacy and Safety of Givosiran (ALN-AS1) in Patients With Acute Hepatic Porphyrias (AHP)

Who this might be right for
Acute Hepatic PorphyriaAcute Intermittent PorphyriaPorphyria, Acute Intermittent+4 more
Alnylam Pharmaceuticals 94
Not applicableEnded earlyNCT03547297
What this trial is testing

INSIGHT-AHP: A Study to Characterize the Prevalence of Acute Hepatic Porphyria (AHP) in Patients With Clinical Presentation and History Consistent With AHP

Who this might be right for
Acute Hepatic PorphyriaHepatic PorphyriasAcute Intermittent Porphyria (AIP)+4 more
Alnylam Pharmaceuticals 212